DORNASE ALPHA: THREE CLINICAL EFFECTS
Chronic diseases of lungs are characterized by the presence of mucostasis which is the reason for often aggravations of bron chopulmonary process and favors progression of the disease. The article convincingly shows the necessity of inclusion mucolytic therapy in baseline therapy in the treatment of...
Main Author: | O.I. Simonova |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2008-03-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Online Access: | https://pf.spr-journal.ru/jour/article/view/872 |
Similar Items
-
DORNASE ALPHA: THREE CLINICAL EFFECTS
by: O.I. Simonova
Published: (2008-03-01) -
OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS
by: O.I. Simonova
Published: (2011-07-01) -
OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS
by: O.I. Simonova
Published: (2011-01-01) -
DORNASE ALFA: WHAT EFFECTIVENESS OF MEDICATION DEPENDS ON?
by: O.I. Simonova
Published: (2009-07-01) -
DORNASE ALFA: WHAT EFFECTIVENESS OF MEDICATION DEPENDS ON?
by: O.I. Simonova
Published: (2009-01-01)